Physician profile
Ryan P Townsend
NPI 1508826843
$998.34
in general payments reported to CMS, 2019-2025
12 companies · $22.28 in 2025
The $22.28 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $622 · 2022: $354 · 2025: $22.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $551.11 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $125.00 | 2021 | |
| Abbvie INC. | $112.42 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $45.34 | 2021 | |
| Ironshore Pharmaceuticals INC. | $28.32 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $26.63 | 2021-2022 | |
| Abiomed | $22.28 | 2025 | |
| Supernus Pharmaceuticals, INC. | $21.49 | 2021 | |
| Axsome Therapeutics, INC. | $19.51 | 2022 | |
| Almatica Pharma LLC | $17.91 | 2021 | |
| Eisai INC. | $14.40 | 2021 | |
| Indivior INC. | $13.93 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Townsend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.